Skip to main content

Nonprofit · EIN 68-0299230

COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS

Tax-exempt · WASHINGTON, DC 20001

Financials

$1.1M$944K2023$1M$951K2024$1.1M$985K2025
Revenue Expenses · by fiscal year end
Financials of COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$1,060,959$985,425$75,534$2,046,219$471,126$1,575,093
December 31, 2024990$1,037,648$951,147$86,501$2,200,649$701,655$1,498,994
December 31, 2023990$1,068,092$944,251$123,841$2,091,287$679,556$1,411,731
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$0
Program service revenue
$1,017,805
Investment income
$43,154
Other revenue
$0

Expenses

Grants and similar amounts paid
$6,000
Compensation of officers, directors and key employees
$268,020
Salaries, compensation and benefits (total)
$268,020
Professional fundraising fees
$0
Legal fees
$27,560
Accounting fees
$12,750
Travel
$42,896

Balance sheet and other

Total assets, start of year
$2,200,649
Total assets, end of year
$2,046,219
Total liabilities, end of year
$471,126
Net assets, end of year
$1,575,093
Net assets without donor restrictions
$1,575,093
Gross receipts
$1,060,959
Employees
0
Volunteers
22
Year formed
1993
State of legal domicile
DC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
MICHAEL GUASTELLAEXECUTIVE DIRECTOR
Officer
40$268,020
DAVID PELLICCIARINICHAIRMAN
Trustee or director, Officer
1$0
SHAHE BAGERDJIANVICE CHAIRMAN
Trustee or director, Officer
1$0
JAMES HARVEYSECRETARY/TREASURER
Trustee or director, Officer
1$0
SHAEMUS GLEASONDIRECTOR
Trustee or director
1$0
SHAHE BAGERDJIANDIRECTOR
Trustee or director
1$0
ROHAN JAINDIRECTOR
Trustee or director
1$0
MICHAEL PINTEKDIRECTOR
Trustee or director
1$0
JIM WILSONDIRECTOR
Trustee or director
1$0
CHRIS WAGNERDIRECTOR
Trustee or director
1$0
JASON VAN WARTDIRECTOR
Trustee or director
1$0
PAUL GAUTHIERDIRECTOR
Trustee or director
1$0
MICHELLE MATHYDIRECTOR
Trustee or director
1$0
ROGER ESTAFANOSDIRECTOR
Trustee or director
1$0
SCOTT CLAUNCHDIRECTOR
Trustee or director
1$0
7 more people on this return
NameTitleHours / weekCompensation
MICHAEL GWINNERDIRECTOR
Trustee or director
1$0
ERIC SCHUTTDIRECTOR
Trustee or director
1$0
DOMINIC SIEWKODIRECTOR
Trustee or director
1$0
CAMPBELLE MONGILIADIRECTOR
Trustee or director
1$0
PATRICK SMITHDIRECTOR
Trustee or director
1$0
ROY BROWNDIRECTOR
Trustee or director
1$0
AMOS HEDTDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2024: 23 people
NameTitleHours / weekCompensation
MICHAEL GUASTELLAEXECUTIVE DIRECTOR
Officer
40$260,040
JOHN WIGGINSCHAIRMAN
Trustee or director, Officer
1$0
DAVID PELLICCIARINIVICE CHAIRMAN
Trustee or director, Officer
1$0
JAMES HARVEYSECRETARY/TREASURER
Trustee or director, Officer
1$0
SHAEMUS GLEASONDIRECTOR
Trustee or director
1$0
SHAHE BAGERDJIANDIRECTOR
Trustee or director
1$0
ROHAN JAINDIRECTOR
Trustee or director
1$0
MICHAEL PINTEKDIRECTOR
Trustee or director
1$0
JIM WILSONDIRECTOR
Trustee or director
1$0
CHRIS WAGNERDIRECTOR
Trustee or director
1$0
JAY SIMONDIRECTOR
Trustee or director
1$0
VITTORIO PUPPODIRECTOR
Trustee or director
1$0
IRA GOLDMANDIRECTOR
Trustee or director
1$0
ROGER ESTAFANOSDIRECTOR
Trustee or director
1$0
SCOTT CLAUNCHDIRECTOR
Trustee or director
1$0
WAYNE MULLETDIRECTOR
Trustee or director
1$0
ERIC SCHUTTDIRECTOR
Trustee or director
1$0
GEOFF TOWLEDIRECTOR
Trustee or director
1$0
CAMPBELLE MONGILIADIRECTOR
Trustee or director
1$0
PATRICK SMITHDIRECTOR
Trustee or director
1$0
ROY BROWNDIRECTOR
Trustee or director
1$0
SHANE COBBDIRECTOR
Trustee or director
1$0
JAMES COOKDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2023: 22 people
NameTitleHours / weekCompensation
MICHAEL GUASTELLAEXECUTIVE DIRECTOR
Officer
40$251,280
STEVE LAFLINCHAIRMAN
Trustee or director, Officer
1$0
DAVID PELLICCIARINIVICE CHAIRMAN
Trustee or director, Officer
1$0
IRA GOLDMANSECRETARY/TREASURER
Trustee or director, Officer
1$0
SHAEMUS GLEASONDIRECTOR
Trustee or director
1$0
CHRIS LOWEDIRECTOR
Trustee or director
1$0
JOHN WIGGINSDIRECTOR
Trustee or director
1$0
MICHAEL PINTEKDIRECTOR
Trustee or director
1$0
JIM WILSONDIRECTOR
Trustee or director
1$0
CHRIS WAGNERDIRECTOR
Trustee or director
1$0
JAY SIMONDIRECTOR
Trustee or director
1$0
SERGIO CALVODIRECTOR
Trustee or director
1$0
RICH MCFERRONDIRECTOR
Trustee or director
1$0
JAMES HARVEYDIRECTOR
Trustee or director
1$0
SCOTT CLAUNCHDIRECTOR
Trustee or director
1$0
WAYNE MULLETDIRECTOR
Trustee or director
1$0
ERIC SCHUTTDIRECTOR
Trustee or director
1$0
ALEXANDRE GIBIMDIRECTOR
Trustee or director
1$0
CAMPBELLE MONGILIADIRECTOR
Trustee or director
1$0
MATTHEW SANFORDDIRECTOR
Trustee or director
1$0
ROY BROWNDIRECTOR
Trustee or director
1$0
JONATHAN CIRTAINDIRECTOR
Trustee or director
1$0

Address and contacts

Address (IRS master file)
500 N CAPITOL ST NW STE 210, WASHINGTON, DC 20001-7407
In care of
% HENRY H KRAMER
Principal officer (990 for 2025)
JAMES HARVEY, 1300 PICCARD DRIVE SUITE LL 14, ROCKVILLE, MD 20850
Signed the 990
JAMES HARVEY, SECRETARY/TREASURER
Phone
(202) 547-6582
Return prepared by
CLIFTONLARSONALLEN LLP

Mission

CORAR IS THE TRADE ASSOCIATION AND VOICE OF THE RADIONUCLIDES AND RADIOPHARMACEUTICALS INDUSTRY IN NORTH AMERICA. CORAR ADVOCATES FOR PUBLIC POLICIES THAT IMPACT HEALTH CARE, TRANSPORTATION SAFETY, HOMELAND SECURITY, AND MANUFACTURING IN AN EFFORT TO EXPAND ACCESS TO SAFE AND AFFORDABLE HEALTH CARE TREATMENTS FOR ALL.

990 for the year ended December 31, 2025

Program accomplishments

  • MONITORED, REPRESENTED, AND ASSISTED PROCATIVELY IN REGULATORY AND LEGISLATIVE PROCESSES AT ALL GOVERNMENT LEVELS THAT ENSURE REASONABLE REGULATIONS AND LEGISLATION ON THE DEVELOPMENT, MANUFACTURE, TRANSPORTATION, USE, SERVICE, AND DISPOSAL OF RADIOACTIVE PRODUCTS USED IN MEDICINE AND THE LIFE SCIENCES. PROMOTED AWARENESS OF THE BENEFITS OF SUCH PRODUCTS AND SERVICES TO LEGISLATORS AND REGULATORS.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
68-0299230
Tax-exempt status
501(c)(6): Business league or chamber of commerce
Donations deductible
No
Exempt since
1993
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$2,046,219
Income (IRS master file)
$1,060,959

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$1,060,959$985,425$2,046,219XML
990December 2024$1,037,648$951,147$2,200,649XML
990December 2023$1,068,092$944,251$2,091,287XML
990December 2022$899,428$875,782$1,555,856IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 68-0299230).

Questions about COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS

What is the EIN of COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS?
The employer identification number (EIN) of COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS is 68-0299230.
Is COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1993.
Are donations to COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS tax-deductible?
No. The IRS master file says contributions to it are not deductible.
Which annual return does COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS?
The 990 for the year ended December 31, 2025 names JAMES HARVEY.
Who are the officers and directors of COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS?
The 990 for the year ended December 31, 2025 lists 22 people; 1 received compensation from the organization, the highest $268,020 (MICHAEL GUASTELLA, EXECUTIVE DIRECTOR).
How much revenue does COUNCIL ON RADIONUCLIDES & RADIOPHARMACEUTICALS have?
On its 990 for the year ended December 31, 2025 it reported revenue of $1,060,959, expenses of $985,425 and total assets of $2,046,219 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia